A Common Ground For rDNA Adversaries

It’s not easy, at first sight, to discern signs of ideological harmony between biologists who are working toward the environmental dissemination of genetically altered organisms and “activists” who are deeply apprehensive about the idea. Look more closely, however, and one argument appears as a possible basis for unity: the need for far greater investment in the ecological research necessary for prudent development of this novel range of technologies. As reflected in the ag

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

It’s not easy, at first sight, to discern signs of ideological harmony between biologists who are working toward the environmental dissemination of genetically altered organisms and “activists” who are deeply apprehensive about the idea. Look more closely, however, and one argument appears as a possible basis for unity: the need for far greater investment in the ecological research necessary for prudent development of this novel range of technologies.

As reflected in the agenda for the First International Conference on the Release of Genetically Engineered Microorganisms (REGEM 1), which opens April 5 in Cardiff, Wales, the potential applications of organisms carrying recombinant DNA in agriculture, medicine and other domains are extremely impressive in their range and promise. Yet at least some of those rewards may be slow to accrue unless much greater effort is put into fundamental environmental studies that will provide guidance for both scientists and regulatory authorities.

“It is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Bernard Dixon

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo